Swan Capital’s Marvell Technology MRVL Stock Holding History

Swan Capital’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.8K	Sell	80 -32	-29%	-$6.42K	0.01%	136
2026 Q1	$11.1K	Buy	112 +12	+12%	+$1.01K	﹤0.01%	191
2025 Q4	$8.5K	Sell	100 -4	-4%	-$350	﹤0.01%	186
2025 Q3	$8.74K	Buy	104 +4	+4%	+$294	﹤0.01%	171
2025 Q2	$7.74K	Hold	100	–	–	﹤0.01%	182
2025 Q1	$6.16K	Buy	+100	New	+$9.7K	﹤0.01%	174

Other funds holding MRVL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swan Capital's MRVL Position: Q2 2026 in Review

Swan Capital reduced its Marvell Technology (MRVL) stake by 29% in Q2 2026, selling an estimated $6.42K and leaving 80 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #136.

Swan Capital first reported a position in MRVL in Q1 2025 and has held it in 6 quarters since. 2,217 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

Swan Capital held 80 shares of Marvell Technology worth $23.8K as of Q2 2026.
Swan Capital sold 32 Marvell Technology shares in Q2 2026, an estimated $6.42K.
Marvell Technology made up 0.01% of Swan Capital's portfolio in Q2 2026, its #136 holding.
Swan Capital first reported a position in Marvell Technology in Q1 2025 and has held it in 6 quarters since.
2,217 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.